|
Vol. 36 Nš 3 |
Lat. Am. J. Pharm. 36 (3): 425-636 (2017) |
REGULAR ARTICLES |
|
|
Molecular Authentication of Panax japonicus through Development of Sequence Characterized Amplified Regions (SCAR) Marker *
ZHANG C., XU C., LI J., YUAN Q., LIU C., WANG T., HE Y., ZHOU Z., DUN Y., ZHAO H. & YUAN D. (431)
|
|
|
|
Dexamethasone Alters the Expression of Scar-Related Genes in Biliary Fibroblasts Induced by TNF-a *
LI K., SHI C., HUANG J. & TANG K. (437)
|
|
|
|
Determination of Six Lignans in Saururus chinensis Rhizome from Different Harvesting Seasons by HPLC-DAD *
CHEN H., CHEN Y., CHEN J., CAI B. & LI X. (443)
|
|
|
|
Determination of Ketoprofen and Sodium Acetate in High Concentration of Ketoprofen Injection by HPLC *
ZHANG S., WANG J., CHEN Y., WANG S., LUO L., LUO Y. & LIU H. (448)
|
|
|
|
Sex-Dependent Pharmacokinetics of Puerarin in Rats After Single Oral Administration *
ZHONG Y., LUO S., WANG L., WANG M., LIN X., YANG L., YE F. & CHEN L. (456)
|
|
|
|
Food Effects on the Pharmacokinetics of Rosuvastatin Calcium Tablet After Administration of a Single Oral Dose in Healthy Chinese Subjects *
ZONG S., ZHOU W., ZHANG Q., HUANG M. & WANG M. (462)
|
|
|
|
Insight into the Binding Interaction Between Orlistat and Human Serum Albumin via Multiple Fluorescence Spectroscopy and Molecular Modeling *
CHEN C., DUAN J., ZHANG C., YAO H., WEI Q. & LI Y. (467)
|
|
|
|
Potential Drug-Drug Interaction between Piceatannol and Anaesthetic Drug Propofol *
HUANG D., XIU Y., HAN N., XIAO L. & SUN H. (474)
|
|
|
|
Protective Effects of Hydrangenol on PC12 Cells Injury Induced by Oxygen and Glucose Deprivation- Reoxygenation *
ZHANG W., SHI J., & MENG A. (479)
|
|
|
|
Anti-inflammatory Activity of Some Newly 8-Hydroxy-7-iodo-5-sulfonamide Quinolines Linked Different Heterocyclic Ring Systems *
KHALIFA N.M., AL-OMAR M.A. & NOSSIER E.S. (486)
|
|
|
|
Pharmacokinetics and Bioavailability of Quercitrin in Lindera aggregata Leaf Extract in Rats *
XU B., CHEN M., HAN H., XU X. & TIAN J. (495)
|
|
|
|
Determination of Flumatininb in Rat Plasma by UPLC-MS/MS: Application to a Pharmacokinetic Study *
CHEN M., WANG S., HAN A., GENG P., LI Y., WEI M., ZHOU Y. & XIAO J. (502)
|
|
|
|
LC-MS/MS and Nanoparticle Immunoassay for Determination of 5-Fluorouracil: Method Comparison, Relative Analysis and Clinical Applications *
GENG C., LI P., ZHANG R., GAO M., CHEN X., GUO N., BU F., LI R. & GUO R. (508)
|
|
|
|
Determination of Oxypaeoniflorin in Rat Plasma after Intravenous Administration by UPLCMS/ MS and its Application to a Pharmacokinetic Study *
LEI H., CHEN M., SONG H., TONG S., YOU P., WANG X. & WANG S. (515)
|
|
|
|
Approach of Hospital Pharmacists towards Adverse Drug Reaction Reporting in Pakistan *
RAHIM N., SHAKEEL S., IFFAT W., NAEEM MUHAMMAD I., AHMED KHAN M. & NESAR S. (521)
|
|
|
|
A Sensitive and Rapid Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Metoclopramide Hydrochloride in Human Plasma *
RAMESH N. & SHABARAYA R. (527)
|
|
|
|
Antioxidant Activity of Some Newly Synthesized Substituted Pyrenyl Pyridine Derivatives *
KHALIFA N.M., AL-OMAR M.A., NOSSIER E.S. & GHANEM H.Z. (535)
|
|
|
|
Quality Control Assessment of Selected Market Tablet Brands of Flurbiprofen and Influence of Accelerated Stability Condition on Dissolution Profiles and Chemical Assay *
SUBHAN A., BIBI H., KHAN B.A., KHAN K.A., HUQ Z.U., ULLAH F., MUSTAFA G., HAIDER F., KHAN Z. & KHAN H. (541)
|
|
|
SHORT COMMUNICATIONS |
|
|
Novel bis-Enone Derivatives: Preparation and Inhibiting Meningiomas Cell Growth *
LIU J., XIAO J., LV S., ZHU X., JIANG Q. & CHENG Z. (549)
|
|
|
|
Pharmacokinetic Study of Ciprofibrate in Rat After Oral Administration by High Performance Liquid Chromatography *
WANG Y., LIN Z., WANG Q., SU K., WEN C., ZENG M. & WANG X. (553)
|
|
|
|
QSAR-Based Lipidomics to Elucidate the Toxicity of Eye Diseases Treatment with Drug Diclofenac *
YU H., CHEN N., LIU S., YU Y., ZHANG F. & PAN J. (557)
|
|
|
|
Metabolic Inhibition Evaluation of Anti-Ovarian Cancer Drug Candidate Praeruptorin E *
WANG Y., CHU H. & CHE Y. (562)
|
|
|
|
The Plasma Level of ALT Can Predict the Metabolic Rate of Arctigenin Derivative *
MOU X., MA D., YU X., & LIU M. (567)
|
|
|
|
Potential Drug Utilization Risk of 3-n-Butylphthalide (NBP) Due to the Inhibition on the Activity of Human Carboxylesterase (CES) *
WU F., JIANG B., LI B. & WU X. (572)
|
|
|
|
Two Novel La(III) and Zn(II) Complexes Based on Aromatic Tricarboxylic Acid Ligands for Inhibiting Growth of Human Skin Cancer Cells *
NIUG., ZHENG W. & JIA Z. (576)
|
|
|
|
The Active Metabolite of Ticagrelor Disturbs the Metabolic Elimination of Lung Cancer Treatment Drug Irinotecan *
ZHANG, J. (580)
|
|
|
|
Ear-Nose-Throat (ENT) Diseases Treatment Drug Difenidol Affects the Activity of Drug-Metabolizing Enzymes (DMEs) *
JIN P., XIA F., SHI C. & LI F. (585)
|
|
|
|
Stilbenoid Trimers and Dimers as Potent Non-Competitive Inhibitors of a-Glucosidase from Rhizomes of Cyperus rotundus L. *
DENG S., XIA L., ZHU J., CAI M., WANG X. & ZHU X. (590)
|
|
|
|
Synthesis and Anti-Inflammatory Activity Against Myocarditis of a New Ca(II)-Based Coordination Compound *
TIAN H., LI S., FU Y., HU K., ZAN Y. & SU G. (595)
|
|
|
|
Anti-Cancer Drug Vemurafenib Showed Strong Inhibition on the Activity of Drug-Metabolizing Enzymes *
ZHANG Z., GAO Y., ZHAI L., LI M., ZHAO J., ZHANG S., & SHEN J. (599)
|
|
|
|
Abiraterone Disrupts the Metabolism of Testosterone *
HE W., ZHAN J., CHEN R., & SONG L. (603)
|
|
|
|
Influence of the Metabolism of Anti-Leukaemia Drugs by Bisphenol A (BPA) Derivatives Exposed to Children *
TU J., LIU F., JIAO R., YE M., YANG X., SHEN J. & ZHANG S. (606)
|
|
|
|
In Vitro Activity of Synthesized Pyran Derivatives-Inhibitor Against Prostate Cancer *
XIAO Y., ZHANG L., HU W., ZHAO Y., & HU H. (609)
|
|
|
|
Potential Testosterone-Tolterodine Interaction *
HE W., ZHAN J., CHEN R. & SONG L. (613)
|
|
|
|
The Biotransformation of Mangiferin to Norathyriol Increased the Risk of Testosterone Inhibition *
AI H., ZHANG H., LI N., ZHANG Y., CAO F., ZHANG Y. & XUE X. (617)
|
|
|
|
Regulation Role of Thyroxin and Triiodothyronine towards Drug-Metabolizing Enzymes (DMEs) Involved in the Metabolism of Drugs to Treat Klebsiella pneumoniae *
YANG R., KANG R., GUO Y., ZHENG A., ZHAO B., ZHANG Y. & CHEN J. (621)
|
|
|
|
Species Difference for the Glucuronidation Metabolism of Testosterone *
AI H., ZHANG H., LI N., ZHANG Y., CAO F., ZHANG Y. & XUE X. (625)
|
|
|
|
Ticagrelor Affects the Glucuronidation Metabolism of Anti-Epileptic Drug Carbamazepine in Children *
TU J. (629)
|
|
|
|
Praeruptorin Compounds Exhibit Inhibition Towards the Metabolism of Lung Cancer Therapeutic Drug Irinotecan *
GUO L., XIANG M., & SUN B. (633)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|